CN Patent

CN115151254A — 治疗特发性嗜睡症的方法

Assigned to Jazz Pharmaceuticals Ireland Ltd · Expires 2022-10-04 · 4y expired

What this patent protects

本公开涉及用羟丁酸盐混合物(羟丁酸混合盐)治疗特发性嗜睡症。

USPTO Abstract

本公开涉及用羟丁酸盐混合物(羟丁酸混合盐)治疗特发性嗜睡症。

Drugs covered by this patent

Patent Metadata

Patent number: CN115151254A
Jurisdiction: CN
Classification: —
Expires: 2022-10-04
Drug substance claim: No
Drug product claim: No
Assignee: Jazz Pharmaceuticals Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.